TITLE

Antioestrogens in Treatment of Breast Cancer: Value of Nafoxidine in 52 Advanced Cases

AUTHOR(S)
Bloom, H. J. G.; Boesen, Evelyn
PUB. DATE
April 1974
SOURCE
British Medical Journal;4/6/1974, Vol. 2 Issue 5909, p7
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64110037

 

Related Articles

  • Controlled Clinical Trial of L--Dopa and Nafoxidine in Advanced Breast Cancer: An E.O.R.T.C. Study. Engelsman, E.; Heuson, J.C.; der Wijst, J. Blonk-Van; Drochmans, A.; Maass, H.; Cheix, F.; Sobrinho, L.G.; Nowakowski, H. // British Medical Journal;6/28/1975, Vol. 2 Issue 5973, p714 

    Presents a clinical trial of L-Dopa and Nafoxidine in postmenopausal women with advanced breast cancer. Therapeutic use of L-Dopa in the treatment of patients with breast cancer; Failure of L-Dopa to achieve objective remissions in patients; Ineffectiveness of L-Dopa in advanced breast cancer...

  • Comparative Trial of Nafoxidine and Ethinyloestradiol in Advanced Breast Cancer: An E.O.R.T.C. Study. Heuson, J.C.; Engelsman, E.; der Wijst, J. Blonk-Van; Maass, H.; Drochmans, A.; Michel, J.; Nowakowski, H.; Gorins, A. // British Medical Journal;6/28/1975, Vol. 2 Issue 5973, p711 

    Presents a comparative trial of nafoxidine and ethinyloestradiol in post menopausal patients with advanced breast cancer. Difference in the remission rates; Complications associated with ethinyloestradiol; Toxic reactions of nafoxidine on skin and hair.

  • Acute coronary syndrome in a breast cancer patient treated with tamoxifen. Benbrahim, Zineb; Arifi, Samia; Boudahna, Lamiae; Amaadour, Lamiae; Sekkali, Naim; Lahlou, Ikram; Akoudad, Hafid; Mellas, Nawfel; El Mesbahi, Omar // Pan Arab Journal of Oncology;Jun2014, Vol. 7 Issue 2, p10 

    Tamoxifen is a non-steroidal antioestrogen widely used in the treatment of breast cancer. Prolonged exposure to this therapy may result in cardio vascular undesirable events particularly thrombotic events. Arterial effects are rare. We report a case acute coronary syndrome in a locally advanced...

  • ONCOLOGY. Kanaike, Megumi // Journal of Pharmacy Practice & Research;Mar2010, Vol. 40 Issue 1, p72 

    The article presents abstracts on oncology topics including the use of risedronate to prevent bone loss resulting from aromatase inhibitors, the use of cetuximab and radiotherapy for the treatment of advanced head and neck cancer and the use of acupuncture in breast cancer patients receiving...

  • AstraZeneca breast cancer drug gains marketing approval in EU.  // PharmaWatch: Cancer;May 2004, Vol. 3 Issue 5, p7 

    Reports that AstraZeneca PLC has received European marketing approval for its breast cancer drug Faslodex, which is indicated for the treatment of advanced breast cancer in post-menopausal women whose cancer has progressed on previous anti-oestrogen treatments. Company's plan to launch Faslodex...

  • Antioestrogens and breast cancer. Santhanam, S.; O'Byrne, K. J. // Journal of the British Menopause Society;2001, Vol. 7 Issue 1, p21 

    Antioestrogens are among the most widely used agents in the treatment of breast cancer. There has been a recent surge of interest in these compounds because of their potential breast cancer chemopreventive properties. The newer generation of antioestrogens, with increased selectivity and better...

  • Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer? Chodak, G W; Kolvenbag, G J C M // Prostate Cancer & Prostatic Diseases;2001, Vol. 4 Issue 2, p72 

    Breast and prostate cancers are the two predominant hormone-responsive tumours. The use of the antioestrogen tamoxifen in the treatment of breast cancer has evolved over the past 30 y from treatment for advanced breast cancer to prevention. Tamoxifen is currently the endocrine treatment of...

  • anti-oestrogen drugs. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p58 

    An encyclopedia entry for an "anti-oestrogen drugs" is presented. They refer to a group of drugs that contrast the action of the hormone oestrogen. Tamoxifen, which is used in the treatment of certain breast cancers, is said to be the most important of these drugs.

  • A Naturopathic Approach to Breast Cancer. Jurasunas, Serge // Townsend Letter for Doctors & Patients;Jun2003, Issue 239, p98 

    Presents the case for a naturopathic approach to breast cancer. Local disease and conventional treatment; Breast cancer and chronic constipation; Iridology approach; Biological regeneration and detoxification; Regular adjuvant protocol for breast cancer; Additional therapy in advanced cases.

  • Gemcitabine.  // Reactions Weekly;10/2/2010, Issue 1321, p19 

    The article describes the case of a woman who developed pulmonary toxicity following treatment with gemcitabine for locally advanced breast cancer.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics